The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.
AIMS: Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C, the amount of cholesterol in those particles, are closely correlated and, considered separately, are positive risk factors. Plasma levels of apolipoprotein A(1), the main surface protein on HDL part...
Main Authors: | Parish, S, Peto, R, Palmer, A, Clarke, R, Lewington, S, Offer, A, Whitlock, G, Clark, S, Youngman, L, Sleight, P, Collins, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2009
|
Similar Items
-
Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
by: John H. Contois, et al.
Published: (2023-08-01) -
Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness
by: Geyue Qu, et al.
Published: (2021-07-01) -
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
by: Clarke, R, et al.
Published: (2007) -
Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
by: Charlton-Menys, V, et al.
Published: (2009) -
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia
by: Farnier M, et al.
Published: (2014-05-01)